Marshall Wace

company

Summary
Funding Rounds
Investments
Investors

About

Marshall Wace is a global asset manager that offers a diverse range of investors alternative investment solutions.

101 - 250

Highlights

Details

Last Funding Type: Private Equity（PE）
Industries: Asset Management,Finance,Financial Services,Hedge Funds
Founded date: Jan 1, 1997
Number Of Employee: 101 - 250
Operating Status: Active
Investor Type: Hedge Fund

Founded in 1997, Marshall Wace is a hedge fund manager specializing in global long/short equity. The firm has investment management offices in London; New York; and Hong Kong.

Marshall Wace LLP was named Management Firm of the Year by the EuroHedge Awards 2011, reflecting the strong performance delivered by a number of our funds during the year.
The firm is dedicated to the objective of providing its clients with a persistent, risk-adjusted return on their investment. Through a range of products, investors can select funds offering variable sources of alpha and beta, in different combinations, from equity markets around the world.

Marshall Wace brings together two distinct but complementary approaches to asset management. First, traditional, fundamental long/short investing grounded in stock-specific analytical research, and secondly, Marshall Wace TOPS (‘MW TOPS’), the pioneering, and proprietary, systematic, alpha capture strategy.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

—

Marshall Wace has raised a total of — in funding over 2 rounds. Their latest funding was raised on Sep 9, 2015 from a Private Equity（PE） round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Sep 9, 2015	Private Equity（PE）	—	1	—	—	Detail

Investments

Number of Investments

Number of Lead Investments

Marshall Wace has made 14 investments. Their most recent investment was on Dec 5, 2022, when Karyopharm Therapeutics raised $165M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Dec 5, 2022 Karyopharm Therapeutics	Post-IPO Equity	$165M	Health Care	—
Nov 9, 2022 TRM Labs	Series B	$70M	Big Data	—
Sep 6, 2022 21.co	Series Unknown	$25M	Blockchain	Yes
Apr 29, 2022 Turtlemint	Series E	$120M	Financial Services	—
Apr 12, 2022 Circle	Private Equity（PE）	$400M	Banking	—